Acetyl-L-Carnitine

ALCAR

Amino-acid derivative (not a peptide) involved in fatty-acid transport, with modest human data.

Supplement / OTCWeight & MetabolismCognition & Mood

Not FDA-approved. Dietary supplement (ALCAR). Levocarnitine (Carnitor) is FDA-approved for deficiency. This page describes research and public discussion; it is not a recommendation to use.

Overview

Carnitines shuttle long-chain fatty acids into mitochondria. Acetyl-L-carnitine is widely sold as a supplement; injectable L-carnitine (levocarnitine) is FDA-approved for carnitine deficiency.

Mechanism of action

Supports carnitine palmitoyltransferase–mediated fatty-acid transport for β-oxidation and donates acetyl groups.

Benefits & evidence ratings

Treats primary/secondary carnitine deficiency (levocarnitine)A Established / approved
Small weight reduction in meta-analyses of carnitine supplementation (~1–1.3 kg)B Human clinical data
Reduced symptoms in diabetic and chemotherapy neuropathyB Human clinical data

Dosing

Doses show what has been studied or discussed — not guidance. Always follow your prescriber.

SourceDoseFrequencyDurationRoute

Supplement trials

B Human clinical data
1–3 g/day in divided dosesDaily8–52 weeksOral

Carnitor injection label (deficiency)

A Established / approved
Per weight, physician-directedVariesVariesIV

Clinical trials & studies

Safety

Side effects

  • Nausea, GI upset
  • Fishy body odour
  • Agitation in some users

Contraindications

  • Hypothyroidism (may interfere with thyroid hormone)
  • Seizure history (caution)

Interactions

  • Warfarin/acenocoumarol — possible increased INR
  • Thyroid hormone

Long-term safety

Generally well tolerated; possible TMAO increase with chronic L-carnitine intake.

Regulatory status

Supplement / OTC

Dietary supplement (ALCAR). Levocarnitine (Carnitor) is FDA-approved for deficiency.

FAQ

Considering a GLP-1 for weight loss?

Compare licensed telehealth providers by true monthly cost and care quality.

See your top 3 matches